These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9702 related articles for article (PubMed ID: 1615586)
21. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Mizutani Y; Yoshida O; Bonavida B J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929 [TBL] [Abstract][Full Text] [Related]
22. [Combined effect of TNF and anticancer chemotherapeutic agents on murine bladder tumor (MBT-2)]. Ikemoto S; Iimori H; Nishimoto K; Hayahara N; Kamizuru M; Wada S; Hayahara M Hinyokika Kiyo; 1992 Mar; 38(3):285-9. PubMed ID: 1523983 [TBL] [Abstract][Full Text] [Related]
23. Ultrasonic hyperthermia and drugs as therapy for human tumor xenografts. Senapati N; Houchens D; Ovejera A; Beard R; Nines R Cancer Treat Rep; 1982 Aug; 66(8):1635-9. PubMed ID: 7105053 [TBL] [Abstract][Full Text] [Related]
24. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma. Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637 [TBL] [Abstract][Full Text] [Related]
25. Clinical hyperthermia and chemotherapy. Storm FK Radiol Clin North Am; 1989 May; 27(3):621-7. PubMed ID: 2648463 [TBL] [Abstract][Full Text] [Related]
26. [Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro]. Hasumura S; Nagamori S; Fujise K; Homma S; Sujino H; Matsuura T; Shimizu K; Niiya M; Kameda H Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1905-12. PubMed ID: 2543327 [TBL] [Abstract][Full Text] [Related]
27. Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. Nahabedian MY; Cohen RA; Contino MF; Terem TM; Wright WH; Berns MW; Wile AG J Natl Cancer Inst; 1988 Jul; 80(10):739-43. PubMed ID: 3385781 [TBL] [Abstract][Full Text] [Related]
28. Responses of B16 melanoma cell lines, F1 and F10, to hyperthermia, lymphokine-activated killer cells and a combination of both in vitro. Nakayama J; Moroi Y; Toshitani A; Taniguchi S; Okamoto-Inoue M; Hori Y Br J Dermatol; 1992 Feb; 126(2):131-6. PubMed ID: 1536778 [TBL] [Abstract][Full Text] [Related]
29. Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor. Nishita T Osaka City Med J; 1998 Jun; 44(1):73-83. PubMed ID: 9834620 [TBL] [Abstract][Full Text] [Related]
30. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology. Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906 [TBL] [Abstract][Full Text] [Related]
31. Behavioural patterns of tumor cells on chorioallantoic membrane of chick in presence of mouse embryos. Palayoor ST; Batra BK Indian J Exp Biol; 1977 Jan; 15(1):1-7. PubMed ID: 908586 [No Abstract] [Full Text] [Related]
32. Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil. Zhang L; Yang Y; Wei XY; Shi YR; Liu HY; Niu RF; Hao XS J Exp Clin Cancer Res; 2007 Jun; 26(2):201-7. PubMed ID: 17725099 [TBL] [Abstract][Full Text] [Related]
33. Response of mouse sarcoma-180 to cis-platin in combination with radiation & hyperthermia. Rao BS; Devi PU Indian J Med Res; 1996 Jun; 103():315-22. PubMed ID: 8707373 [TBL] [Abstract][Full Text] [Related]
34. Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma. Gold JE; Zachary DT; Osband ME Clin Immunol Immunopathol; 1994 Oct; 73(1):115-22. PubMed ID: 7923908 [TBL] [Abstract][Full Text] [Related]
35. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. van de Vaart PJ; van der Vange N; Zoetmulder FA; van Goethem AR; van Tellingen O; ten Bokkel Huinink WW; Beijnen JH; Bartelink H; Begg AC Eur J Cancer; 1998 Jan; 34(1):148-54. PubMed ID: 9624250 [TBL] [Abstract][Full Text] [Related]
36. Combination radiotherapy and chemotherapy in murine bladder cancer. Weldon TE; Kursh E; Novak LJ; Persky L Urology; 1979 Jul; 14(1):47 52. PubMed ID: 452220 [TBL] [Abstract][Full Text] [Related]
37. Tamoxifen in trimodal therapy with cytotoxic drugs and hyperthermia in vivo significantly enhance therapeutic efficacy against B16-F10 melanoma. Misir Krpan A; Ivankovic S; Krajina Z; Ivankovic D; Stojkovic R Tumori; 2012; 98(2):257-63. PubMed ID: 22677994 [TBL] [Abstract][Full Text] [Related]
38. Additive effects of cepharanthin in CDDP/hyperthermia combination therapy against transplantable human esophageal cancer in nude mice. Yano T; Nakatani K; Watanabe A; Sawada H; Yamada Y; Nakano H; Ohnishi T Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):525-8. PubMed ID: 8005810 [TBL] [Abstract][Full Text] [Related]
39. Long-duration, mild whole body hyperthermia with cisplatin: tumour response and kinetics of apoptosis and necrosis in a metastatic rat mammary adenocarcinoma. Toyota N; Strebel FR; Stephens LC; Matsuda H; Bull JM Int J Hyperthermia; 1997; 13(5):497-506. PubMed ID: 9354934 [TBL] [Abstract][Full Text] [Related]
40. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Nitta K; Tanaka T; Takeuchi M Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]